The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigating the prevalence and risk of chemotherapy-induced neuropathy among cancer patients.
 
Philip Jordache
No Relationships to Disclose
 
Keith Danahey
No Relationships to Disclose
 
Natalie Marie Reizine
No Relationships to Disclose
 
Peter H. O'Donnell
Stock and Other Ownership Interests - allergan
Honoraria - Astellas Pharma; Atheneum; CLD, Inc.; Dedham Group; FirstWord; Genentech/Roche; Health Advances; Janssen; Merck; Pfizer; Schlesinger Associates; Seagen
Consulting or Advisory Role - Merck
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Janssen; Janssen; Merck; Seattle Genetics/Astellas
Other Relationship - Dragonfly Therapeutics; Janssen; Nektar; NIH